IC
IART icon

IEQ Capital’s Integra LifeSciences IART Stock Holding History

IEQ Capital’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.25M Buy
+125,262
New +$1.75M 0.01% 762
2026
Q1 		– Sell
-110,928
Closed -$1.38M – 1982
2025
Q4 		$1.38M Buy
110,928
+99,169
+843% +$1.32M ﹤0.01% 912
2025
Q3 		$169K Buy
+11,759
New +$161K ﹤0.01% 1706

Other funds holding IART

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

IEQ Capital's IART Position: Q2 2026 in Review

IEQ Capital opened a new position in Integra LifeSciences (IART) in Q2 2026: 125,262 shares worth $2.25M. The stake represents 0.01% of the portfolio and ranks #762 among its holdings. This is a return to the name: IEQ Capital previously reported a position in IART as recently as Q4 2025.

IEQ Capital first reported a position in IART in Q3 2025 and has held it in 3 quarters since. 213 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • IEQ Capital held 125,262 shares of Integra LifeSciences worth $2.25M as of Q2 2026.
  • Integra LifeSciences was a new IEQ Capital position in Q2 2026.
  • Integra LifeSciences made up 0.01% of IEQ Capital's portfolio in Q2 2026, its #762 holding.
  • IEQ Capital first reported a position in Integra LifeSciences in Q3 2025 and has held it in 3 quarters since.
  • 213 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.